Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Archives of Paediatric Dentistry
Published in: European Archives of Paediatric Dentistry 6/2020

01-12-2020 | Probiotics | Original Scientific Article

In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes

Authors: E. Gobbi, M. A. De Francesco, G. Piccinelli, A. Caruso, E. Bardellini, A. Majorana

Published in: European Archives of Paediatric Dentistry | Issue 6/2020

Login to get access

Abstract

Purpose

Black extrinsic discoloration is a common clinical and aesthetic problem. This study aims to evaluate the potential in vitro antagonistic activity of two commercial probiotics, Streptococcus salivarius M18 and Lactobacillus reuteri ProDentis, against microorganisms associated with black stains.

Methods

Streptococcus salivarius M18 and Lactobacillus reuteri were tested against Aggregatibacter actinomycetemcomitans and Actinomyces naeslundiiusing their cell-free fermentative broth in a planktonic growth inhibition test.

Results

Both probiotic cell-free supernatants showed the ability to reduce the pathogenic bacteria growth in a dose-dependent way. Streptococcus salivarius M18 showed a stronger antimicrobial activity than Lactobacillus reuteri ProDentis against the two indicator strains used. A. naeslundi was less susceptible to the probiotic activity of both S. salivarius and L. reuteri compared to A. actinomycetemcomitans.

Conclusions

The obtained results demonstrate a potent antagonistic ability of probiotics to reduce the growth of microorganisms associated with black tooth stains. Therefore, these strains could be evaluated for a therapeutic use against dental pigmentations.
Literature
Allaker RP, Stephen AS. Use of probiotics and oral health. Curr Oral Health Rep. 2017;4:309–18.CrossRef
Bardellini E, Amadori A, Gobbi E, et al. Does Streptococcus Salivarius strain M18 assumption make black stains disappear in children? Oral Health Prev Dent. 2020 (in press).
Burton JP, Cowley S, Simon RR, et al. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol. 2011;49:2356–64.CrossRef
Burton JP, Drummond BK, Chilcott CN, et al. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J Med Microbiol. 2013a;62:875–84.CrossRef
Burton JP, Wescombe PA, Macklaim JM, et al. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS ONE One. 2013b;8:e65991.CrossRef
Caglar E, Kuscu OO, Cildir SK, et al. A probiotic lozenge administered medical device and its effect on salivary mutans streptococci and lactobacilli. Int J Paediatr Dent. 2008;18:35–9.PubMed
Cintas LM, Casaus MP, Herranz C, et al. Bacteriocins of lactic acid bacteria. Food Sci Tech Int. 2001;7:281–305.CrossRef
Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard-Eight Edition, CLSI document M11-A8. Wayne: Clinical and Laboratory Standards Institute; 2012.
Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7–A10. Wayne: Clinical and Laboratory Standards Institute; 2016.
de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1–66.PubMed
Ganzle MG, Holtzel A, Walter J, et al. Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol. 2000;66:4325–33.CrossRef
Hattab FN, Qudeimat MA, AlRimawi HS. Dental discoloration: an overview. J Esthet Restor Dent. 1999;11:291–310.CrossRef
HeinrichWeltzien R, Bartsch B, Eick S. Dental caries and microbiota in children with black stain and non-discoloured dental plaque. Caries Res. 2014;48:118–25.CrossRef
Heng NCK, HajiIshak NS, Kalyan A, et al. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius Strain M18. J Bacteriol. 2011;193:6402–3.CrossRef
Itsaranuwat P, Al-Haddad KSH, Robinson RK. The potential therapeutic benefits of consuming ‘health promoting’ fermented dairy products: a brief update. Int J Dairy Technol. 2003;56:203–10.CrossRef
Kang MS, Oh JS, Lee HC, et al. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria. J Microbiol. 2011;49:193–9.CrossRef
Keller MK, Hasslof P, Stecksen-Blicks C, et al. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci; an in vitro study. Acta Odontol Scand. 2011;69:263–8.CrossRef
Koll P, Mandar R, Marcotte H, et al. Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiol Immunol. 2008;23:139–47.CrossRef
Krasse P, Carlsson B, Dahl C, et al. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillusreuteri. Swed Dent J. 2006;30:55–60.PubMed
Lin X, Chen X, Chen Y, et al. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral Dis. 2015;21:e128–e134134.CrossRef
Litty S, Nagarathna D, Merline V. Probiotics in periodontal therapy. Int J Pharm Bio Sci. 2015;6:242–50.
Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci. 2005;113(3):188–96.CrossRef
Reid JS, Beeley JA. Biochemical studies on the composition of gingival debris from children with black extrinsic tooth stain. Caries Res. 1976;10:363–9.CrossRef
Ronay V, Attin T. Black stain-a review. Oral Health Prev Dent. 2011;9:37–45.PubMed
Saba C, Solidani M, Berlutti F, et al. Black stains in the mixed dentition: a PCR microbiological study of the etiopathogenic bacteria. J Clin Pediatr Dent. 2006;30:219–24.CrossRef
Soukos NS, Som S, Abernethy AD, et al. Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother. 2005;49:1391–6.CrossRef
Tagg JR, Dierksen KP. Bacterial replacement therapy: adapting ‘germ warfare’ to infection prevention. Trends Biotechnol. 2003;21:217–23.CrossRef
Talarico TL, Casas IA, Chung TC, et al. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1988;32:1854–8.CrossRef
Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol. 2011;38:159–77.CrossRef
Teughels W, Durukan A, Ozcelik O, et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40:1025–35.CrossRef
Twetman S, Stecksén-Blicks C. Probiotics and oral health effects in children. Int J Paediatr Dent. 2008;18:3–10.PubMed
Twetman S, Derawi B, Keller M, et al. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand. 2009;67:19–24.CrossRef
Vicario M, Santos A, Violant D, et al. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand. 2013;71:813–9.CrossRef
Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J Oral Microbiol. 2010;2:5344.CrossRef
Wescombe PA, Burton JP, Cadieux PA, et al. Megaplasmids encode differing combinations of antibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek Van Leeuwenhoek. 2006;90:269–80.CrossRef
Metadata
Title
In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes
Authors
E. Gobbi
M. A. De Francesco
G. Piccinelli
A. Caruso
E. Bardellini
A. Majorana
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Paediatric Dentistry / Issue 6/2020
Print ISSN: 1818-6300
Electronic ISSN: 1996-9805
DOI
https://doi.org/10.1007/s40368-020-00512-2

Other articles of this Issue 6/2020

European Archives of Paediatric Dentistry 6/2020 Go to the issue

Original Scientific Article

Prevalence of hypomineralised second primary molars (HSPM) in Syrian preschool children

Original Scientific Article

Attitudes of EAPD members toward using the “knee-to-knee” position

Original Scientific Article

Can child safeguarding training be improved?: findings of a multidisciplinary audit

Abstract

Scientific Abstracts of the 15th Congress of the European Academy of Paediatric Dentistry (EAPD), Hamburg, Germany July 3–4, 2020

Systematic Review

Topical fluoride-antibacterial agent combined therapy versus topical fluoride monotherapy in preventing dental caries: a systematic review and meta-analysis

Original Scientific Article

A questionnaire study on perception and clinical management of molar incisor hypomineralisation (MIH) by Irish dentists